Delivery Order SPE2DB20D1100-SPE2DB24FY48G

Award Date 10/18/23
Potential Completion Date 10/19/23
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $5,887.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561328180 Remicade 100 mg vials. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the contractor to provide the specified pharmaceutical products. Performance will occur in Conshohocken, Pennsylvania by the end of June 2023. No set-aside designation or subcontractors were identified. The Defense Logistics Agency...
The Defense Logistics Agency awarded a $14,718 delivery order to Amerisourcebergen Drug Corporation for 4561723599 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the pharmaceutical products to DLA from August 7-8, 2023 for use in agency medical supply programs. Amerisourcebergen will perform the order from its facility located in Conshohocken, Pennsylvania without involvement of major subcontractors. The...
<p>The Defense Logistics Agency awarded a $14,358 delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The firm fixed price order is for performance at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 18-19, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this order supports DOD medical supply needs.</p>
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $36,525 firm fixed price delivery order for 100 mg vials of Remicade. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 1, 2023 under the terms of the order. The Defense Logistics Agency supports Department of Defense procurement through contracts such as this for supplies including medical products. No set aside designation or...
The Defense Logistics Agency awarded a $36,459 delivery order to Amerisourcebergen Drug Corporation for 4561806089 REMICADE 100 MG VIALS. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the specified pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 15, 2023 to support DLA programs. No set aside designation or subcontractors were identified. REMICADE is an immunosuppressive drug used to treat...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $4,415 firm fixed price delivery order contract to provide 100 mg vials of Remicade. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 29, 2023 under the terms of the order. The Defense Logistics Agency utilizes contracts such as this to efficiently acquire necessary medical supplies in support of Department of Defense programs and...
<p>Defense Logistics Agency awarded a $19,178.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milligram vials of REMICADE. The place of performance is Conshohocken, Pennsylvania and the contract completion date is October 19, 2023. No set-aside designation was used for this award to the prime contractor Amerisourcebergen Drug Corporation for pharmaceutical products in support of DLA programs.</p>
The Defense Logistics Agency Troop Support Medical awarded a $12,180 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg vials of Remicade. The place of performance is Conshohocken, Pennsylvania, with performance period spanning August 31, 2023 through September 1, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the rheumatoid arthritis treatment Remicade supports the Defense...
The Defense Logistics Agency Troop Support Medical awarded a $12,362 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562252005 REMICADE 100 MG VIALS. The firm fixed price order is for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania, with performance taking place from September 20-21, 2023. No additional details were provided regarding the original solicitation or whether this delivery order falls under a broader indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566713139 REMICADE 100 MG VIALS, a specialty medication, with a ceiling value of $7,972.80. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FY48G
    Delivery Order

This delivery order for $18,878.52, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the purchase of 4562523541 units of Remicade 100 mg vials. The contract has a firm fixed price and period of performance through October 19, 2023. To be delivered to a location in Conshohocken, Pennsylvania, the vials are likely medical supplies for DLA distribution to military treatment facilities in support of the Agency's mission to provide worldwide logistics support to the Department of Defense and other authorized customers. No set-aside designation was used for this award issued under an existing vehicle by the DLA for pharmaceutical products.

Generated 1/17/24, 10:08 AM